HOME >> BIOLOGY >> NEWS
Pitt Professor awarded competitive Sloan Research Fellowship

PITTSBURGH--Marc Sommer, assistant professor in the University of Pittsburgh's Department of Neuroscience, has received an Alfred P. Sloan Research Fellowship, a competitive award given to the "very best" scientists at an early stage in their faculty careers.

The two-year, $45,000 award will fund Sommer's research into how brain areas communicate with each other during normal behaviors, and how this communication breaks down in such mental disorders as schizophrenia. Sommer studies the signals sent from deep brain structures, such as the cerebellum, to the prefrontal cortex, considered to be the seat of cognitive abilities.

Sommer is investigating how this input to prefrontal cortex normally influences how we see, move, and make decisions, and how the flow of information is altered in an animal model of schizophrenia. To do this, he "eavesdrops" on single nerve cells using fine electrodes with microscopic tips, and also determines the inputs and outputs of the cells.

"Marc's approach, the creativity he brings to what he does, is quite unusual for a starting-out scientist," said Alan Sved, chair of Pitt's neuroscience department. "There's no question in my mind and those of the faculty in the department that Marc is the most outstanding young scientist now working in the area of sensorimotor processing in primate cortex."

The Alfred P. Sloan Foundation, a philanthropic nonprofit institution, was established in 1934 by Alfred Pritchard Sloan Jr., then-president and chief executive officer of the General Motors Corporation. The Sloan Research Fellowships were established in 1955 to provide support and recognition to early-career scientists and scholars, often in their first appointments to university faculties, who were endeavoring to set up laboratories and establish their independent research projects with little or no outside support. Currently, a total of 116 fellowships are awarded annually in seven fields: chemistry, computational
'"/>

Contact: Karen Hoffmann
klh52@pitt.edu
412-624-4356
University of Pittsburgh
5-May-2005


Page: 1 2

Related biology news :

1. UCSB Assistant Professor Patrick Daugherty wins Young Investigator Award from ACS
2. Krber Prize to ETH Zurich Professor Seeberger
3. Professors to develop hand-held pathogen testing device
4. Professor analyzes nuclear receptors in bee genome
5. Professor earns carbon sequestration research grant
6. Tufts David Walt named Howard Hughes Medical Institute Professor
7. Richard Zare named Howard Hughes Medical Institute Professor
8. Stevens Professor Alan Blumberg to speak at New York Public Library
9. Yale Public Health Professor elected fellow of the American Statistical Association
10. Allergies affect 15 million people in UK, says Professor
11. Jan Lwe awarded 2007 EMBO Gold Medal

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pitt Professor awarded competitive Sloan Research Fellowship

(Date:4/17/2014)... engineer has developed a patented technique that improves ... The same technique could help police during drug ... Kay L. Theede chair in engineering and department ... research team have created a template-based system that ... The distance detection method called stand-off bomb ...
(Date:4/17/2014)... is available in German . ... the protection money demanded of him, he can expect his ... however, as fear of the consequences is enough to make ... parasitic birds, which lay their eggs in other birds, nests. ... brood parasites take their revenge by destroying the entire nest. ...
(Date:4/17/2014)... many serious conditions such as heart disease, epilepsy and ... therapies. Unfortunately, there is still much scientists do not ... and unexpected insight into the structure of sodium channels ... - which are responsible for ,fine-tuning, the activity of ... recent edition of the Journal of Biological Chemistry ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3Structure of sodium channels different than previously believed 2
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
(Date:1/14/2014)... Boston, MA (PRWEB) January 14, 2014 iLab ... Michelle Detwiler as the new Director of Product Strategy. In ... as well as iLab sub-teams to guide in the development ... that iLab provides the maximum possible benefit to the scientific ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... 2014   Kinaxis ®, provider of RapidResponse ®, a ... operations planning ( S&OP ) service, is proud to be ... will be held at the Hilton San Diego Bayfront, January ... Elisabeth Kaszas , Director of Supply Chain at Amgen, ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
Cached News: